SAZ VII 23
Latest Information Update: 08 Jan 1997
At a glance
- Originator Nonindustrial source
- Class Antiarrhythmics
- Mechanism of Action Adenosine triphosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 08 Jan 1997 No-Development-Reported for Arrhythmias in USA (Unknown route)
- 17 May 1995 Preclinical development for Arrhythmias in USA (Unknown route)